<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2229">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05132140</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00003210</org_study_id>
    <nct_id>NCT05132140</nct_id>
  </id_info>
  <brief_title>Peripheral Choroidal Layer Response</brief_title>
  <official_title>Peripheral Choroidal Response to Pure Defocus and Oriented Blur Conditions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to examine how the vascular layer of the eyeball (choroidal layer) responds&#xD;
      when part of the visual field is exposed to specially generated visual stimulus. The study&#xD;
      goal will be accomplished by producing specific blur visual stimulus at a particular visual&#xD;
      field position and measure any consistent thickness change pattern in the choroidal layer.&#xD;
&#xD;
      We propose to test the hypothesis that regional changes in the choroidal thickness may be&#xD;
      induced differently after short-term exposure to specific visual stimuli.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>choroidal thickness</measure>
    <time_frame>up to 60 mins</time_frame>
    <description>A commercially available optical coherence tomography system will be used to measure changes in choroidal layer thickness before and after manipulating the peripheral optics.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>normal healthy group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adaptive optics system: this system controls the optical quality of the eye at the peripheral visual field temporarily.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>adaptive optics system</intervention_name>
    <description>the system consists of a wavefront sensor and a deformable mirror that measure and correct (or modify) the eye's optical imperfections (aberrations).</description>
    <arm_group_label>normal healthy group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        A person is eligible for inclusion in the study if he/she:&#xD;
&#xD;
          -  Is between the ages of 18 and 40 yrs old&#xD;
&#xD;
          -  Has normal best corrected visual acuity being 20/20 or better&#xD;
&#xD;
          -  Has spherical refractive error between +1.00D and -6.00D.&#xD;
&#xD;
          -  Is capable of fixating on the target.&#xD;
&#xD;
          -  Has no prior ocular surgery.&#xD;
&#xD;
          -  Has no ocular pathology except keratoconus.&#xD;
&#xD;
          -  Can tolerate dilating eye drops&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        A person will be excluded from the study if he/she:&#xD;
&#xD;
          -  Does not fall within above mentioned age group.&#xD;
&#xD;
          -  Has chronic or systemic eye disease that would interfere with pupil dilation via eye&#xD;
             drops.&#xD;
&#xD;
          -  Underwent ocular surgeries or history of ocular trauma&#xD;
&#xD;
          -  Has shallow anterior chamber angle and/or glaucoma.&#xD;
&#xD;
          -  Has clinically significant dry eye.&#xD;
&#xD;
          -  Has signs of any choroidal or retinal pathology, and abnormalities in the visual&#xD;
             pathway&#xD;
&#xD;
          -  Has spherical refractive error that exceeds the limits outlined above.&#xD;
&#xD;
          -  Has binocular anomalies (e.g. convergence insufficiency, strabismus, pseudo-myopia,&#xD;
             amblyopia).&#xD;
&#xD;
          -  Is an adult unable to consent&#xD;
&#xD;
          -  Is an individual who is not yet adult (infants, children, teenagers)&#xD;
&#xD;
          -  Is a pregnant woman&#xD;
&#xD;
          -  Is a prisoner&#xD;
&#xD;
          -  Is a student for whom you have direct access to/influence on grades&#xD;
&#xD;
          -  Is an economically and/or educationally disadvantaged person&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Geunyoung Yoon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Geunyoung Yoon, PhD</last_name>
    <phone>7137437860</phone>
    <email>gyoon2@central.uh.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dibyendu Pusti, PhD</last_name>
    <phone>5854069837</phone>
    <email>dpusti@central.uh.edu</email>
  </overall_contact_backup>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 11, 2021</study_first_submitted>
  <study_first_submitted_qc>November 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2021</study_first_posted>
  <last_update_submitted>November 23, 2021</last_update_submitted>
  <last_update_submitted_qc>November 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Houston</investigator_affiliation>
    <investigator_full_name>Geunyoung Yoon</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

